BACKGROUND: Apolipoprotein (apo) A-II is a major structural protein of plasma HDLs, but little is known regarding its functions. METHODS AND RESULTS: To investigate the physiological role of apoA-II in humans, we screened the promoter region of the apoA-II gene for a functional polymorphism and used this polymorphism as a tool in association studies. A common, functional polymorphism in the promoter region of the apoA-II gene, a T to C substitution at position -265, was found. Electrophoretic mobility shift assays demonstrated that the -265T/C polymorphism influences the binding of nuclear proteins, whereas transient transfection studies in human hepatoma cells showed a reduced basal rate of transcription of the -265C allele compared with the -265T allele. The -265C allele was associated with decreased plasma apoA-II concentration and decreased waist circumference in healthy 50-year-old men. In addition, oral fat tolerance tests provided evidence that the -265C allele enhances postprandial metabolism of large VLDLs. CONCLUSIONS: ApoA-II appears to promote visceral fat accumulation and impair metabolism of large VLDLs.
BACKGROUND: Apolipoprotein (apo) A-II is a major structural protein of plasma HDLs, but little is known regarding its functions. METHODS AND RESULTS: To investigate the physiological role of apoA-II in humans, we screened the promoter region of the apoA-II gene for a functional polymorphism and used this polymorphism as a tool in association studies. A common, functional polymorphism in the promoter region of the apoA-II gene, a T to C substitution at position -265, was found. Electrophoretic mobility shift assays demonstrated that the -265T/C polymorphism influences the binding of nuclear proteins, whereas transient transfection studies in humanhepatoma cells showed a reduced basal rate of transcription of the -265C allele compared with the -265T allele. The -265C allele was associated with decreased plasma apoA-II concentration and decreased waist circumference in healthy 50-year-old men. In addition, oral fat tolerance tests provided evidence that the -265C allele enhances postprandial metabolism of large VLDLs. CONCLUSIONS:ApoA-II appears to promote visceral fat accumulation and impair metabolism of large VLDLs.
Authors: Jean Michel Petit; Valerie Jooste; Laurence Duvillard; Anne Minello; Véronique Texier; Françoise Galland; Philippe Gambert; Bruno Verges; Patrick Hillon Journal: Dig Dis Sci Date: 2007-04-11 Impact factor: 3.199
Authors: S Krapivner; E Chernogubova; M Ericsson; C Ahlbeck-Glader; A Hamsten; F M van 't Hooft Journal: Diabetologia Date: 2006-11-15 Impact factor: 10.122
Authors: Dolores Corella; Gina Peloso; Donna K Arnett; Serkalem Demissie; L Adrienne Cupples; Katherine Tucker; Chao-Qiang Lai; Laurence D Parnell; Oscar Coltell; Yu-Chi Lee; Jose M Ordovas Journal: Arch Intern Med Date: 2009-11-09
Authors: Lawrence W Castellani; Cara N Nguyen; Sarada Charugundla; Michael M Weinstein; Chau X Doan; William S Blaner; Nuttaporn Wongsiriroj; Aldons J Lusis Journal: J Biol Chem Date: 2007-12-26 Impact factor: 5.157
Authors: Caren E Smith; Katherine L Tucker; Donna K Arnett; Sabrina E Noel; Dolores Corella; Ingrid B Borecki; Mary F Feitosa; Stella Aslibekyan; Laurence D Parnell; Chao-Qiang Lai; Yu-Chi Lee; José M Ordovás Journal: J Nutr Date: 2013-10-09 Impact factor: 4.798
Authors: Chao-Qiang Lai; Caren E Smith; Laurence D Parnell; Yu-Chi Lee; Dolores Corella; Paul Hopkins; Bertha A Hidalgo; Stella Aslibekyan; Michael A Province; Devin Absher; Donna K Arnett; Katherine L Tucker; Jose M Ordovas Journal: Am J Clin Nutr Date: 2018-07-01 Impact factor: 7.045